News

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for milsaperidone (Bysanti ™) for the treatment of acute bipolar I disorder and schizophrenia.
Bipolar disorder is a serious mental health ... making it hard to tell whether it is a result of withdrawal or a relapse. Another concern is that if you restart the medication later, the treatment ...
Relapse prevention is why most people seek treatment, and with opioid use disorders (OUDs), there’s about a 90 percent relapse rate. This article explains why and how specific sayings from self ...
But when I was seven, the odds felt insurmountable.”—Terri Cheney, The Dark Side of Innocence: Growing Up Bipolar Bipolar disorder, formerly called manic depression, has had a long twisted ...
Danny Evans (left) lives with bipolar disorder and is a presenter in the “In Our Own Voice” program with the Minnesota chapter of the National Alliance on Mental Illness (NAMI). He poses for a ...
A new documentary giving a "raw and unfiltered view" of TV chef Heston Blumenthal's life following his bipolar diagnosis has been commissioned by the BBC. The English restaurateur, who presented ...
Johns Hopkins is seeking people who have a diagnosis of bipolar I disorder to participate in a research study. The purpose of this study is to create a database of information that allows researchers ...
Actress Ryoko Hirosue will take a break from showbiz after being diagnosed with bipolar disorder and hyperthyroidism, her agency said Friday. Her agency said on its website that Hirosue, 45, has been ...
However, 50% of responding patients will relapse either due to evolution of CD19 negative disease or early loss of CAR T-cells so that only around 40% of patients are cured by the currently ...